Developing new methods to create targeted therapies for Alzheimer's disease
Engineering and application of modular chimeric tRNA synthetases in mRNA display
This study is exploring new ways to create special treatments for Alzheimer's disease that can better target the proteins causing the condition, with the hope of offering patients more effective options to slow down its progression or ease symptoms.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11071528 on NIH RePORTER |
What this research studies
This research focuses on engineering modular chimeric tRNA synthetases to enhance the development of macrocyclic peptide therapeutics (MPTs) that can effectively target proteins involved in Alzheimer's disease. By utilizing advanced techniques to incorporate non-canonical amino acids into peptides, the research aims to improve the specificity and binding affinity of these therapeutics. Patients may benefit from new treatment options that can more effectively disrupt the processes leading to Alzheimer's disease, potentially slowing its progression or alleviating symptoms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective therapies for Alzheimer's disease, improving patient outcomes.
How similar studies have performed: Previous research has shown promise in using similar approaches to target difficult proteins, indicating potential for success in this area.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Ellis, Jonathan M — Univ of North Carolina Chapel Hill
- Study coordinator: Ellis, Jonathan M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.